Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on July 21, 2026, the Compensation Committee of Guardants Board of Directors approved the granting of restricted stock units (RSUs) representing 46,044 shares of its common stock to 149 new non-executive...